(97) suggests that nintedanib successfully down-regulates the expression of α-SMA, collagen-1, chemokine receptor 2 and very late antigen 4 in bleomycin-induced pulmonary fibrosis, as well as an upregulation of GRK2 activity in peripheral blood neutrophils. The gene discussed is GRK2; the disease is pulmonary fibrosis.